Protein phosphatase 4 regulates apoptosis, proliferation and mutation rate of human cells  by Mourtada-Maarabouni, Mirna & Williams, Gwyn T.
Biochimica et Biophysica Acta 1783 (2008) 1490–1502
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrProtein phosphatase 4 regulates apoptosis, proliferation and mutation
rate of human cells
Mirna Mourtada-Maarabouni ⁎, Gwyn T. Williams ⁎
Institute for Science and Technology in Medicine, Huxley Building, Keele University, Keele, ST5 5BG, UK⁎ Corresponding authors. G.T. Williams is to be conta
fax: +44 1782 583516. M. Mourtada-Maarabouni, Tel.: +
583516.
E-mail addresses: bia19@biol.keele.ac.uk (M. Mourta
g.t.williams@keele.ac.uk (G.T. Williams).
0167-4889/$ – see front matter © 2008 Elsevier B.V. Al
doi:10.1016/j.bbamcr.2008.03.005A B S T R A C TA R T I C L E I N F OArticle history: The proteins which regulate
Received 13 September 2007
Received in revised form 1 February 2008
Accepted 3 March 2008
Available online 20 March 2008
Keywords:
Protein phosphatase 4
Apoptosis
Cell cycle
Bad
PEA-15
Tumour suppressorapoptosis are of great importance both in normal cell biological processes and in
the development of pathology in the diverse diseases which involve apoptosis dysfunction. The activity of
many of these proteins is controlled by reversible phosphorylation, so that the relevant kinases and
phosphatases play crucial roles in apoptosis control. Here we report the analysis of the role of the serine/
threonine protein phosphatase, protein phosphatase 4, in controlling the apoptosis of HEK 293 T cells, using
the complementary techniques of gene over-expression and down regulation through RNA interference. This
analysis has demonstrated that PP4 regulates both apoptosis and proliferation in human cells and has also
shown that the level of PP4 has a strong inﬂuence on gene mutation rate, which is crucial to oncogenesis. A
parallel proteomic analysis has shown that the phosphorylation status of many relevant protein targets is
affected by changes in PP4 and has focused attention particularly on the critical apoptosis regulators Bad and
PEA-15. The phosphorylation of both of these proteins is increased when PP4 levels are suppressed, and is
reduced when PP4 levels are increased, with striking consequences for the fate of the cell.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The reversible phosphorylation of serine and threonine residues
on target proteins is a critical regulatory mechanism in apoptosis, in
common with many other cellular processes. Proteins important in
apoptosis control which are reversibly phosphorylated include several
members of the Bcl-2 family, including Bcl-2 itself [1], Bad [2], Bid [3]
and Bik [4], as well as Forkhead transcription factor (FKHLR; [5]) and
Caspase 9 [6].
The phosphorylation status of all of these serine/threonine
phosphorylated proteins at any time is the result of the balance
between the activities of protein kinases, such as CK2 [7], and the
activities of serine/threonine phosphatases. Although crucial to the
activity of many of the target proteins, the protein phosphatases have
only recently received the attention required to develop an under-
standing of the regulatory process [24]. Serine/threonine protein
phosphatases typically act on a number of target proteins, many of
which have yet to be identiﬁed, and their effects on cell signaling and
other cellular processes are therefore complex.
Protein phosphatase 4 (PP4; PPP4; PPX) is a ubiquitous highly
conserved serine/threonine phosphatase, now recognised to regulatected at Tel.: +44 1782 583032;
44 1782 583679; fax: +44 1782
da-Maarabouni),
l rights reserved.many pathways within the cell independently of the related phos-
phatase PP2A (reviewed by Cohen et al. [8]). The catalytic subunit of
PP4 (PP4c) interacts with two regulatory subunits R1 and R2, which
regulate and control its activity. PP4c has been implicated in the
nucleation, growth and maturation of the centrosome during cell
division [9–12] and in spliceosomal assembly via interaction with the
survival of motor neurones (SMNs) complex [13]. Although the sub-
cellular localistation of PP4c is mainly nuclear [14], some PP4c is
cytoplasmic, suggesting that PP4c plays diverse cellular functions in
addition to its roles in cell division and in spliceosomes. Indeed, PP4c
has also been reported to regulate NFκB [15], and JNK [16], to interact
with the target of rapamycin (TOR) pathway [17], to interact with
insulin receptor following TNFα stimulation [18] and, most recently,
to regulate histone deacetylase activity [19].
Since PP4 affects such diverse pathways, its effects on cell
survival are complicated. In many, if not all, eukaryotic cells, a
minimum level of PP4 activity is likely to be necessary for cell
survival and proliferation, not least because of its important role
in centrosome maturation [9–12]. The recent observations of de-
creased cell survival in mouse thymocytes where PP4 has been
deleted are consistent with this [20]. On the other hand, a PP4c
cDNA sequence was isolated by an unbiased functional screen for
genes regulating apoptosis, and over-expression of PP4 induced
apoptosis in mouse thymoma cells [21]. The reduction in endo-
genous PP4 in these cells (presumably at levels of PP4 expression
which remained above the minimum level needed for normal cell
survival) was associated with resistance to Dexamethasone-
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Fig. 1. PP4c over-expression inhibits cell growth and increases apoptosis in 293T cells. (A) Immunoblot of PP4c protein expression in 293T-pcDNA.1/PP4c-transfected cells (lane 3),
293T-pcDNA3.1-transfected cells (lane 2) and 293T parental cells (lane1). Each lane contains 50 μg of whole-cell lysate subjected to SDS-polyacrylamide gel electrophoresis (PAGE),
followed by Western blot analysis with anti-PP4c antibody. β-actin was used as a loading control. The resulting autoradiographs were analysed by densitometry. A representative
autoradiograph is presented, and the bar graph represents mean±S.E. from 4 independent experiments. Relative expression is the ratio of PP4c level versus β-actin (B) The expression
of PP4c in 293T cells transfected with PP4c, relative to cells transfected with pcDNA3.1, was determined by quantifying PP4c mRNA levels by qRT-PCR, using the comparative method,
normalised to 18S as internal control. Results are represented as mean±standard error of the mean (S.E.) from ﬁve separate experiments, ⁎Pb0.01 compared with vector only. (C)
Growth curve of 293T, 293T-pcDNA3.1-transcfected cells and 293T-pcDNA3.1/PP4c-transfected cells over 72 h. Cell density was determined by nigrosin dye exclusion (C) and MTS
assay (D). Results are expressed as the mean±S.E., and are representative of data obtained from ﬁve separate experiments, ⁎Pb0.01 compared with vector only and parental cells. (E)
Active caspase staining, as a marker of apoptosis, was determined using CaspaTag kit and ﬂuorescence microscopy. Data are represented as the mean±S.E from ﬁve separate
experiments, ⁎Pb0.01 compared with vector only. (F) Cell cycle analysis of 293T-pcDNA3.1-transfected cells and 293T-pcDNA3.1/PP4c-transfected cells. DNA content was quantiﬁed
by propidium iodide staining of ﬁxed cells and ﬂuorescence ﬂow cytometry. Results are represented as the mean±S.E. (n=5). Representative histograms are shown.
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tually exclusive and together suggest that both insufﬁcient PP4
activity, and excessive PP4 activity, is lethal to the cell.
In order to investigate the role of PP4 in the control of survival in a
human cell system, we have analysed the effects of speciﬁc modu-
lation of PP4 levels in Human Embryo Kidney 293T cells. Using PP4
expression plasmids to increase PP4 levels and PP4 siRNA to decrease
endogenous PP4 levels, we have observed a consistent inverse
correlation between cell survival and proliferation, on the one hand,
and PP4 expression levels near or above the endogenous level, on the
other hand.We also report the results of a parallel proteomics study of
the effects of changes in endogenous PP4 levels on the phosphory-
lation status of a number of important candidate target proteins.
These studies have allowed us to identify several proteins likely to play
signiﬁcant roles in the regulation of cell survival by PP4.
2. Materials and methods
2.1. Materials
Cisplatin (#155663-27-1), Butyrate (#B5887), Okadaic acid (#04511) and Dex-
amethasone (#D4902) were purchased from Sigma.
2.2. Cell culture
HEK 293T cells were grown in RPMI 1640 medium supplemented with 10% heat
inactivated fetal calf serum (Hyclone), 2 mM L-glutamine and 200 μg/ml gentamycin
(Sigma), at 37 °C in a 5% CO2 humidiﬁed incubator. All experiments were carried out
using cells in logarithmic growth phase. Plasmids were transfected into 293T cells with
GeneJammer transfection reagent (Stratagene; #2041.30) according to the manufac-
turer's instructions at a 3:1 ratio (GeneJammer/DNA). PP4 expression was veriﬁed by
western analysis and qRT-PCR.
Determination of cell viability and detection of apoptosis. Cell viability was
determined by nigrosin exclusion analysis and by the MTS assay, (Promega; # G5421).The CaspaTag TM Fluorescein Caspase Activity Kit (Intergen; # S7300-025) was used to
detect active caspases in the cells as a marker for apoptosis, according to the manu-
facturer's instructions. Detection was performed using a ﬂuorescence microscope.
3. Preparation of cells for cell cycle analysis
Preparation of cells and nuclear Propidium Iodide (PI) staining procedure for cell
cycle analysis was performed according to standard procedures [39,40]. One million
cells were suspended in 200 μl PBS, and ﬁxed in 2ml ice cold 70% ethanol/30% PBS. After
30 min incubation on ice, the cells were centrifuged for 5 min at 2000 rpm and the
supernatant aspirated. Cells were resuspended in 970 μl PBS, 3 μl RNase (DNAse free;
Sigma R4642) and 40 μl of PI (1mg/ml) and incubated for 30min at 37 °C before analysis
using the MoFlo ﬂow cytometer (Dako Cytomation).
4. Clonogenic assay
Long-term survival of cells transfected with PP4c, or with PP4c siRNAs, was
assessed by the ability of the cells to form colonies in soft agar. An equal proportion of
the culture from each experimental condition was diluted in 5 ml Iscove's medium
(Sigma) containing 20% heat inactivated fetal calf serum, 10% 293T-conditioned
medium and 0.3% noble agar (Difco) and plated in 60 mm dishes. Dishes were overlaid
with 2.5 ml Iscove's complete medium containing 10% cell-conditioned medium. The
number of colonies formed was counted following 2–3 weeks incubation at 37 °C in 5%
CO2 and 95% air.
2.5. RNA interference
Two different PP4c siRNAs were purchased from Ambion (PP4s1 siRNAs ID#
105835; PP4s2 siRNA ID# 105834. Negative siRNA (siRNACat # 4605) and GAPDH (Cat #
4605) gene-speciﬁc pre-designed siRNAwere purchased from Ambion. All siRNAs were
HPLC puriﬁed, annealed and ready to use. siRNA transfection ™ transfection reagent
(Qiagen, # 301605), following the manufacturer's instructions. To analyse the siRNA
transfection efﬁciency, siRNA duplexes were labelled with Cy3 using the Silencer™
siRNA labelling kit (Ambion; Cat # 1632), following themanufacturer's instructions, and
transfection efﬁciencies (ﬂuorescently labelled cells after 48 h) were 90–95%.
Monitoring of speciﬁc silencing of PP4c expression was carried out after 48 h by qRT-
PCR and western blotting.
Fig. 3. The enzymatically inactive PP4 mutant PP4RL does not inhibit cell proliferation
or colony-forming ability. 293T cells were transfected with pcDNA3.1, pcDNA3.1/PP4c,
pCL-neo or pCL-neo/PP4RL. (A) Growth curve of transfectants over 72 h. Cell density
was determinedMTS assay. (B) Colony forming ability of transfectants. Cells were plated
in soft agar 24 h post transfection, colonies were counted after two weeks. Results
represent means±S.E. and are representative of data obtained from ﬁve independent
experiments, ⁎Pb0.01 compared with vector only.
Fig. 2. PP4c over-expression promotes cell death induced by different apoptotic stimuli.
293T cells were transfected with pcDNA3.1 or pcDNA3.1/PP4c. 24 h post transfection,
cells were treated either with 40 J/m2 UV, 5 μg/ml cisplatin, 30 nM okadaic acid or 5mM
butyrate. Viable cell number was determined after 48 h (A) and after 96 h (B). Results
represent means±S.E. and are representative of data obtained from ﬁve independent
experiments, ⁎Pb0.01 compared with vector only.
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The expression of PP4c in over-expressing cells and in PP4c knockdown cells was
determined using real-time RT-PCR. 5 μg of total cell RNAwas reverse transcribed using
Superscript™ II Rnase H− Reverse Transcriptase and random primers (Promega)
according to the manufacturers instructions (Invitrogen; #18064). Real-time PCR was
performed using 2 μl of the cDNA (equivalent to 500 ng of the total RNA) and Taq Man
MGB probes and primers speciﬁc to human PP4c (Applied Biosystems; Assay ID: Hs
00427262-m1) with eukaryotic 18S rRNA as an endogenous control (Applied Bio-
systems; Assay ID: Hs99999901_s1), according to the manufacturers instructions.
Quantitation of PP4c gene transcripts in PP4c-transfected clones and PP4c knockdown
cells relative to pcDNA3.1 clones or (−)siRNA cells was determined using the com-
parative CT method, using parental cells as calibrators. The ABI Prism 7000 sequence
detection system was used to measure real-time ﬂuorescence, and data analysis was
performed using ABI Prism 7000 SDS software.
2.7. Western blot analysis
106 cells were washed twice in PBS and lysed in 50 μl lysis buffer (50 mM Tris–HCl,
pH 7.5; 150 mM NaCl, 1% Nonidet P40, 1 mM EDTA, 1 μM Pepstatin, 10 μg/ml Leupeptin,
1 mM PMSF). The cell suspension was then incubated on ice for 30 min before
centrifugation at 10,000 ×g for 10 min. The protein content in the supernatant was
quantiﬁed using the Coomassie Plus™ protein assay reagent (PIERCE; # 1856210).
Protein samples (50 μg) were boiled for 10min in SDS-PAGE sample buffer (10% glycerol,
0.7 M β-mercaptoethanol, 3% SDS, 62 mM Tris–HCl, pH 6.8), subjected to 12% SDS-PAGE
and then electrotransferred onto a polyvinylidenediﬂuoride membrane (Biorad). The
blots were probed with either the anti-PP4c (PPX/PP4 (C-18) 1:1000 dilution; Santa
Cruz Biotechnology # Sc6118), Anti-Bad antibody (Santa Cruz Biotechnology # Sc8044),
anti-PEA-15 antibody (Santa Cruz # Sc28255), phosphospeciﬁc anti-PEA15 (P-PEA15,
dilution 1:500; Biosource Anti-PED/PEA [pS116] # 44-836G), or phosphospeciﬁc anti-Bad (anti-P-Bad [pS136], Biosource; # 44-524G), followed by the appropriate horse-
radish peroxidase-conjugated secondary antibodies. Blots were stripped using ReBlot
Plus Kit (Chemicon; # 2500) and reprobed with anti-β-actin antibody (dilution 1:5000;
Sigma, # A5441). The secondary antibodies used were anti-goat IgG (diluted 1:10.000;
Sigma, # A5420), anti-mouse immunoglobulin (diluted 1:800; Dako, # P0447) and anti-
rabbit IgG (diluted 1:10000; Sigma, # A0545). Protein bands were visualised by
enhanced chemiluminescence (ECL) according to the manufacturer's instructions
(Amersham Pharmacia Biotech). For quantitation, the hyperﬁlm ECL ﬁlms used for the
autoradiography were preﬂashed at 0.05 optical density. Densitometric analysis was
carried out using GS-800 scanner (Biorad) and Quantity one software (Biorad).
2.8. Measurement of HPRT mutations
Mutagenesis rates were determined as previously described [42,43]. UV irradiation
from the UVG-54 lamp (UVP) was routinely monitored using the J-225 Black-Ray UV
(shortwave) intensity meter (SER# 44725). The irradiation from the UVwas 2W/m2 at a
distance of 25 cm. 106 Cells were exposed to UV in plastic petri dishes with the lids
removed for 20 s at a distance of 25 cm (40 J/m2). After UV exposure, the irradiated
mediumwas replaced by fresh RPMImedium, cells were incubated for 10 days at 37 °C in
95% air: 5% CO2, at an initial density of 5×105 cells/ml, followed by cloning in soft agar.
5×105 cells/plate were used in the presence of 50 μM 6-thioguanine (Sigma; # A4660),
since colony-forming efﬁciency is low under these conditions. 200 cells/platewere used
in the absence of 6-thioguanine since colony-forming efﬁciency is much higher under
these conditions. The mutation frequency, corrected for cell cloning efﬁciency, was
calculated as [(mean colony count per plate in presence of 6-thioguanine) / (cells per
plate in selective medium)/(surviving fraction in non selective medium)].
2.9. Kinetworks™ phosphoprotein analysis
Detergent-solubilized extracts (500 µg of protein) from transiently transfected
293T cells were subjected to Kinetworks Phospho-Site Screening (KPSS) 8.0 as
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screens use panels of 61 highly validated commercial phosphosite-speciﬁc antibodies
and 20-lane multichannel blotters. The intensities of the ECL signals for the target
protein bands on the Kinetworks immunoblots were quantiﬁed with a FluorS Max
Imager and Quantity One software (Bio-Rad). (Detailed information and protocols of the
Kinetworks analysis can be found at the Kinexus Bioinformatics Corporation Web site;
www.kinexus.ca.).
2.10. Statistical analysis
Data are presented as the mean±standard error of the mean (S.E.). Statistical
signiﬁcance was determined by analysis of variance using Origin 6.1. A p value of b0.01
was considered statistically signiﬁcant.Fig. 4. PP4c speciﬁc siRNAs increase cell proliferation. 293T cells were transfected with con
endogenous PP4c RNA was determined. The expression of endogenous PP4c in 293T transfe
Results are represented as mean±S.E. (for PP4c expression relative to untransfected cells) fro
protein under the same conditions was determined by Western blotting and equivalent load
analysed by densitometry. A representative autoradiograph is presented, and the bar graph re
of PP4c level versus β-actin (C) Growth curve of 293T GAPDH siRNA, 293T (−)siRNA-treated
using MTS assay. Data represent means±S.E. from ﬁve independent experiments, ⁎Pb0.01 c3. Results
3.1. Effects of over-expression of PP4c on HEK 293T cell apoptosis and
proliferation
HEK 293T cells, widely used for transient protein expression, were
transiently transfected with a pcDNA3.1 expression plasmid contain-
ing full length cDNA encoding PP4c. After 24 h, PP4c expression was
analysed by western blotting (Fig. 1A) which revealed a 2.5–3.5 fold
increase in PP4c protein level and qRT-PCR which showed that PP4c
transcript levels were increased by an average of 7–10 fold (Fig. 1B).trol (−)siRNA or with PP4c-speciﬁc siRNA. (A) 48 h after transfection, the expression of
cted with PP4c siRNAs was compared with that in the cells transfected with (−)siRNA.
m ﬁve separate experiments, ⁎Pb0.01 compared with vector only. (B) Expression of PP4c
ing was demonstrated using anti β-actin antibody. The resulting autoradiographs were
presents mean±S.E. from ﬁve independent experiments. Relative expression is the ratio
and 293T PP4s2 and PP4s1 siRNA-treated cells over 72 h. Cell density was determined
ompared with vector only and parental cells.
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considerably decreased at 48 h and 72 h as compared to cultures of
untransfected cells and cells transfected with empty vector, as
assessed both by vital dye staining (Fig. 1C) and by the MTS assay
(Fig. 1D). Cells over-expressing PP4c also showed a 15–20% increase in
apoptotic cells, conﬁrming the pro-apoptotic effect of over-expressing
PP4c in these adherent human cells (Fig. 1E).
In order to determine whether the growth suppression produced
by PP4c was due to apoptosis, to cell cycle arrest, or to both, a cell cycle
analysis was performed using propidium iodide staining and ﬂow
cytometry. The results revealed that the proportion of cells in G1 inFig. 5. PP4c knockdown inhibits cell death mediated by UV, cisplatin and butyrate. 72 h po
treated cells were exposed to 40 J/m2 UV, 5 μg/ml cisplatin or 5 mM butyrate. Cell density wa
butyrate, (B) cisplatin and, (C) after UV exposure. (D) Representative photograph of 293T (−)s
E. from ﬁve independent experiments, ⁎Pb0.01 compared with vector only and parental cePP4c over-expressing cultures is consistently higher than that in the
controls and the percentage of cells in S phase is consistently lower,
suggesting that PP4c may promote arrest in the cell cycle in G1
(Fig. 1F). In addition, cultures of PP4c over-expressing cells showed a
substantial increase in the proportion of cells in the sub-G0 fraction,
conﬁrming that the apoptosis rate in these clones is indeed increased
(Fig. 1F).
We also examined the effects of PP4c on apoptosis induced by
cisplatin, UV, butyrate and okadaic acid, at 24 h after transfection. As
shown in Fig. 2A, PP4c over-expressing cells were consistently more
sensitive to UV-, cisplatin-, butyrate- and okadaic acid-induced cellst siRNAs transfection, 293T GAPDH, 293T (−)siRNA and 293T PP4s2 and PP4s1 siRNA-
s determined over the following 72 h using the MTS assay. Cell density in presence of (A)
iRNA, 293T PP4s2 and PP4s1 293Tcells 96 h after UV exposure. Data represent means±S.
lls.
Fig. 6. Modulation of PP4c expression affects colony-forming ability and mutation
frequency at the HPRT locus in 293T cells. (A) 293T Cells transfected with either
pcDNA3.1, pcDNA3.1/PP4c, pCl-neo, pCL-PP4-RL, (−)siRNA, PP4s1 and PPP4s2 siRNAs
were exposed to UV 40J/m2, and colony-forming ability was determined 48 h after UV
exposure. Results are expressed as means±S.E. from ﬁve independent experiments,
⁎Pb0.01 compared with vector only and parental cells. (B) Mutation frequencies at the
HPRT locus in 293T cells transfected with either pcDNA3.1, pcDNA3.1/PP4c, pCl-neo,
pCL-PP4-RL, (−)siRNA, GAPDH siRNA, PP4s1 or PP4s2. 10 days post UV irradiation.
Following UV exposure, cells were incubated in freshmedium for 10 days at 37 °C in 95%
air: 5% CO2, at an initial density of 5×105 cells/ml, followed by cloning in soft agar in the
presence of 50 μM 6-thioguanine. Data represent means±S.E. from ﬁve independent
experiments, ⁎Pb0.01 compared with vector only and parental cells.
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live PP4c over-expressing cells remained constant after the treatment
with UV, okadaic acid and butyrate, whereas the number of live
vector-only transfected cells increased (Fig. 2A), suggesting that PP4c
was inhibiting cellular proliferation and that apoptosis was occurring
more rapidly in the PP4c over-expressing cells than in the controls.
Interestingly, the effects of PP4c on cisplatin-induced apoptosis
appeared to be transient and reversible, since, after 96 h, the number
of live PP4c over-expressing cells consistently increased to a level
higher than the number of cells transfected with empty vector
(Fig. 2B). These later increases in cell number after transient over-
expression of PP4c and cisplatin treatment did not occur when other
cell lines such CEM-C7 and Jurkat T cells were transiently transfected
with PP4c, and transient expression of PP4c in CEM-C7 and Jurkat cells
made these cells very sensitive to cisplatin (manuscript in prepara-
tion). To ensure that the observed effects were due to PP4 activity, we
have performed more experiments using the phosphatase-dead PP4
mutant in the expression vector pCI-neo (Promega) (pCl-PP4-RL)
which was constructed by substituting the arginine (Arg-235) in the
phosphatase domainwith leucine [16,41]. Our results show that while
over-expression of PP4 inhibited cell proliferation and decreased
colony-forming ability, these effects were not seen with the
enzymatically inactive form of the polypeptide. Indeed, over-expres-
sion of PP4-RL mutant appeared to increase cell proliferation and
colony-forming ability slightly, although the effects were not
statistically signiﬁcant (Fig. 3A and B).
3.2. Effects of the PP4c knockdown on HEK 293T apoptosis and
proliferation
Since over-expression studies do not necessarily indicate physio-
logically important effects, we used RNA interference to down
regulate endogenous PP4c expression in 293T cells. PP4s1 and PP4s2
siRNA were transfected into 293T cells and the PP4c RNA level was
monitored using qRT-PCR. PP4s1 and PP4s2 siRNA transfected cells
had PP4c levels which were reduced by 7- to 10-fold, whereas control
(−)siRNA and GAPDH siRNA had no effect on PP4c levels (Fig. 4A).The
suppression of PP4c expression was also conﬁrmed by western
blotting (Fig. 4B) which revealed 70–80% reduction in PP4c protein
level. PP4c knockdown stimulated cell proliferation, as measured both
at 48 h and at 72 h, as shown in Fig. 4C. Down regulation of PP4c
suppressed UV-, butyrate- and cisplatin-induced cell apoptosis
(results not shown). As shown in Fig. 5A and B, cells transfected
with PP4c siRNAs were resistant to UV, butyrate and cisplatin. These
cells were able to grow normally after 72 h and 96 h, in contrast to the
control (−)siRNA and GAPDH siRNA transfected cells and parental
cells. These results strongly suggest an interaction between PP4 and
components of the apoptosis regulatory machinery. PP4c knockdown
did not affect okadaic acid-induced apoptosis (results not shown),
presumably because okadaic acid also strongly inhibits other serine/
threonine phosphatases [11,22].
3.3. The effects of PP4c over-expression on cell survival and mutation
rates after UV irradiation
The colony-forming ability of 293T cells was substantially reduced
after 40 J/m2 UV exposure and pcDNA3.1/PP4c transfection enhanced
the loss of colony-forming ability of these cells after UV irradiation
(Fig. 6A). Consistently with this, suppression of PP4c signiﬁcantly
protected cells from the loss of colony-forming ability induced by UV
(Fig. 6A). PP4-RL, the enzymatically inactive mutant form of the
phosphatase, also appeared to protect partially against the UV-
induced loss of colony-forming ability, although this protection was
not statistically signiﬁcant. These striking and reproducible observa-
tions strongly support a role for PP4 in inducing apoptosis after DNA
damage. Since induction of apoptosis in cells which have sustaineddamage to their DNA is a critical element in eliminating potentially
oncogenic mutations, we analysed the production of mutant HPRT−
cells after UV exposure in PP4 transfected cells and in PP4 siRNA
transfected cells. A signiﬁcant decrease in the mutation rate was seen
in PP4c over-expressing cells (Fig. 6B), whereas cells transfected with
PP4c siRNAs showed a substantial increase in the mutation rate (Fig.
6B). PP4-RL transfected cells also showed an increase in the mutation
rate, which, although smaller than that produced by RNA interference,
was still statistically signiﬁcant (Fig. 6B). These clear-cut observations
again support an important and rate-limiting role for PP4 activity in
the induction of the apoptosis which normally acts to prevent the
survival of mutated cells which, potentially, may have progressed
signiﬁcantly towards the production of a cancer.
3.4. Effects of alterations in PP4 catalytic subunit levels on cellular
phosphoproteins
To monitor signalling pathways targeted by PP4c, we utilized
Kinetworks phosphoprotein analysis (Kinexus; Kineticwork™, KPSS
Fig. 7.Modulation of PP4c expression changes the phosphorylation level of many proteins in 293T. (A)Western blot analysis was used to examine phosphorylation of 30 proteins at 61
known sites. Bands of interest are labeled with the corresponding proteins. (B) and (C) Normalised differences between 293T parental and 293T transfected with pcDNA3.1/PP4c and
PP4s2 which revealed several proteins with marked changed in phosphorylation levels.
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phosphorylation status of 61 phosphosites in over 30 known proteins
involved in apoptosis and cellular stress. Phosphorylation of thesesites was compared in parental cells, in PP4c-over-expressing cells,
and in PP4c knockdown cells, using phosphosite-speciﬁc antibodies to
monitor the phosphorylation state of key proteins in cellular lysates.
Fig. 8 (continued).
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signiﬁcant changes in the phosphorylation state of several proteins
involved in cellular apoptosis and cell proliferation (Fig. 7A; Full
Kinexus report provided as Supplementary data). These proteins
include Activating Transcription Factor 2 (ATF2), Coﬁlin 1, Double-
stranded RNA-dependent Protein-serine Kinase (PKR), c-Fos, Heat
shock 25 kDa protein (Hsp25), Heat shock 27 kDa protein beta 1
(Hsp27), Akt1 (PKB), STAT3, ERK1 and ERK2 (Fig. 8B and C; STAT3,
ERK1 and ERK2 blots are supplied as Supplementary data). Most
signiﬁcantly, down regulation of PP4 caused an increase in Bad (S136)
phosphorylation by 40% and a dramatic increase in PEA-15 phosphor-
ylation (223%) (Fig. 7C), providing further evidence supporting the
involvement of PP4 in regulating apoptosis.
PP4c over-expression caused an increase in the phosphorylation of
several proteins (Fig. 7A), where such increases in phosphorylation
induced by over-expression of a phosphatase presumably reﬂect
activation of kinases, directly or indirectly, by removal of phosphate
groups by PP4. These observations therefore illustrate the complexity
of the cellular phosphorylation/dephosphorylation systems involved.
ERK1 (T202+Y204) phosphorylation was decreased in both PP4 over-
expressing and PP4c knockdown cells (Fig. 7B).
Based upon the Kinetworks analysis of 293T cell lines, we
examined the role of PP4 in regulating PEA-15 and Bad phosphoryla-
tion by immunoblotting. Western blot analysis on proteins extracted
from 293T cells over-expressing PP4 and from PP4 knockdown cells,
using phosphospeciﬁc antibodies, revealed that Bad and PEA-15
phosphorylation state did indeed increase when PP4c expression was
suppressed, and that over-expression of PP4c caused a corresponding
decrease in the phosphorylation state of these proteins. (Fig. 8).
4. Discussion
Our previous work has implicated PP4c in regulating apoptosis in
murineW7.2 thymoma cells. In this report, we further demonstrate that
PP4c is an importantmodulator of apoptosis and cell proliferation in the
human adherent cell line HEK 293T and we have extended our analysis
to identify speciﬁc proteins regulated by PP4c. Our experiments have
demonstrated that over-expression of PP4c can suppress cell prolifera-
tion by inducing apoptosis and promoting cell cycle arrest in G1 (Fig. 1).
We have also shown that over-expression of PP4c enhances cell death
induced by UV, butyrate and okadaic acid (Fig. 2). Interestingly, the
effects of PP4c on the 293T cell death induced by the chemotherapeutic
agent cisplatin appeared to be transient. At 96 h post transfection, cells
that transiently over-expressed PP4c become resistant to cisplatin and
were able to grow normally in the presence of this agent, so that
transient over-expression of PP4c appears to desensitise 293T cells to
cisplatin (Fig. 2B). An orthologue of a mammalian PP4 subunit, Pph3,
confers resistance to cisplatin in the yeast Sacchraromyces cerevisiae
[25]. Our work also shows that down regulation of PP4c by 70–80%,
using speciﬁc PP4 siRNA, increased the rate of cell proliferation and
conferred resistance to UV, cisplatin and butyrate. Down regulation of
PP4c did not inhibit cell death induced by okadaic acid, presumably
because okadaic acid strongly inhibits another phosphatase, PP2A, with
a comparable IC50 [11,22]. It is likely that cells in which PP4 expression
has been reduced bymore than 70–80%may not be viable, since PP4c is
required formicrotubule nucleationduring centrosomematuration [12].
Our results contrast with a previous report which studied the
effects of PP4 expression on the proliferation of the breast cancer cellFig. 8. PP4c regulates the phosphorylation state of PEA-15 and Bad.Western Blot analysis usin
expression and knockdown on the phosphorylation level of these proteins. Each lane contai
total PEA-15 antibody, lane 1 293T, lane 2 293T-pcDNA3.1 and lanes 3 and 4 293T-pcDNA3.1
lane 1 293T (−)siRNA, lane 2 293TGAPDH siRNA, lane 3 293T PP4s1 and lane 4 PP4s2. (C) Us
293T-pcDNA3.1, lane 3 and 4 293T-pcDNA3.1/PP4c. (D)Using phosphospeciﬁc anti-Bad antibo
293T PP4s1 and lane 4 293T PP4s2. Anti-β-actin antibody was used as a loading control. The r
software. Relative expression is the ratio of total PEA-15, P-PEA15, total BAD or P-BAD v
Representative autoradiographs are shown⁎.line MCF7 [26], indicating that PP4c suppression could result in cell
death in that cell line. Such a discrepancy may be due to the use of
different approaches to down regulate PP4. While we used the siRNA
approach, Lifeng et al. ampliﬁed PP4c sequence from MCF7 by RT-PCR
which was used as antisense. Depletion of PP4 below the level
required for cell survival, as discussed above, could therefore account
for the results reported by Lifeng et al. [26].
Genomic instability is characteristic of many types of human
cancer. This instability accelerates the mutation rate and the random
acquisition of genetic changes which confer a growth or survival
advantage over normal cells. Our data shows that PP4c over-
expression reduces the mutation in the indicator gene, hypoxanthine
phosphoribosyl transferase (hprt), whereas PP4c down regulation
increased its mutation frequency. These observations, which are
clearly consistent with a rate-limiting role for PP4 in the induction of
apoptosis after DNA damage, have important implications for
carcinogenesis and support the hypothesis that PP4c may function
as a tumour suppressor gene.
The interplay between the different targeting regulatory subunits
of PP4 appears to be central to its function and association of PP4R1
and PP4R2 subunits with PP4c limit the range of PP4c activity [27–29].
Interestingly, PP4R1, which is not involved in targeting PP4c to the
centrosome and therefore in cell division, was identiﬁed in a
sensitized RNAi screen as a survival polypeptide, suggesting binding
of PP4R1 to PP4c may promote cell survival via the inhibition of PP4c
activity [30]. Furthermore, PP4R1 was detected by serological
identiﬁcation of leukaemia-derived antigens by recombinant expres-
sion cloning (SEREX [31]).
To identify the cellular pathways targeted by PP4c, we initially
employed the Kinetworks screen to analyse a wide range of
phosphoproteins in 293T cells transfected with PP4c or PP4c siRNAs.
Many proteins involved in cellular stress, cellular proliferation and
apoptosis exhibited changes in their phosphorylation state, increases
as well as reductions, reﬂecting the complexity of the signalling
pathways that are regulated by PP4c. The proteins which are likely to
be direct substrates of PP4c and which showed the predicted pattern
of decreased phosphorylation in the cell lines with elevated PP4c and
increased phosphorylation in cells low level of PP4c, were coﬁlin,
ERK2, Bad, STAT3 and PEA-15. The effects of PP4c on the phosphor-
ylation levels of these proteins, several of which play previously
established roles in the control of apoptosis and/or the cell cycle,
provide further support for a critical role for PP4 in regulating cell
survival and proliferation. The dephosphorylated form of coﬁlin, an
actin-binding protein, translocates to the mitochondria after induc-
tion of apoptosis before release of cytochrome c. Phosphorylation of
coﬁlin is reported to suppress its mitochondrial translocation and
apoptosis [32]. STAT3 is classiﬁed as proto-oncogene and STAT3
phosphorylation is elevated in human rhabdomyosarcomas, osteos-
comas and soft tissue sarcoma cells [33]. ERK2, a serine/threonine
kinase acts as an important activator of RSK and STAT3. ERK2 is
involved in the MAPK pathway and has been implicated in cell
proliferation, differentiation, and survival (reviewed by Turjanski et al.
[23,34]). A high nuclear basal level of ERK2 phosphorylation contributes
to the resistance of cisplatin-resistant human ovarian cancer cells [35],
so that the increase of ERK2 phosphorylationwe observed as a result of
PP4c suppressionmay explain the cisplatin resistance conferred on cells
with low level of PP4c. Bad, a crucial BH3-only pro-apoptotic Bcl-2
family protein, has been shown to be phosphorylated extensively ong phosphospeciﬁc anti-PEA-15 and anti-Bad antibodies to study the effects of PP4c over-
ns 50 μg of whole-cell lysate. (A)Using phosphospeciﬁc anti-PEA-15 antibody and anti-
/PP4c (B) Using phosphospeciﬁc anti-PEA-15 antibody and anti-total PEA-15 antibody,
ing phosphospeciﬁc anti-Bad antibody and anti-total Bad antibody. Lane 1 293T, lane 2
dy and anti-total Bad antibody. Lane 1 293T (−)siRNA, lane 2 293T GAPDH siRNA, lane 3
esulting radiographs were analysed by densitometry, and the data analysed using Origin
ersus β-actin expression. Each bar represents the mean±S.E. from four experiments.
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regulator of cell death and survival. The phosphorylation of Bad
prevents its dimerization with Bcl-xL leading to the inhibition of
cytochrome c release to the cytosol and subsequent caspase-3 acti-
vation, so leading to greater cell survival [2,36]. Finally, phosphorylation
of PEA-15 (Phosphoprotein Enriched in Astrocytes of 15 kDa) was found
to dramatically increase by 223% when PP4c expression was reduced.
PEA-15 is reported to modulate signalling pathways that control
apoptosis and cell proliferation [37]. PEA-15 is regulated by multiple
calcium-dependent phosphorylation pathways that account for its
existence in a non-phosphorylated form in equilibrium with a
phosphorylated form. In normal mammary epithelium, the non-
phosphorylated form of PEA-15 binds to ERK1/2 and prevents its
nuclear accumulation, thereby blocking cell proliferation [38]. Phos-
phorylated PEA-15, on the other hand, does not block cell proliferation
but it is recruited to the DISC (Death inducing signalling complex) to
block the extrinsic pathway of apoptosis [38]. These observations
further focus attention on the importance of the ERK pathways in the
control of apoptosis.
Our present report provides strong evidence that PP4c plays a
crucial role in the control of apoptosis, cell proliferation and mutation
rate in human cells, potentially acting through the dephosphorylation
of several critical apoptosis regulators, particularly PEA-15 and Bad
(total protein levels of PEA-15 and Bad are not signiﬁcantly affected by
transient modulation of PP4 (Fig. 8)). Although further studies are
required to identify more PP4c targets and to clarify the signalling
pathways regulated by PP4c, it is clear that PP4c and other phos-
phatases are potential targets for novel therapeutic applications in the
many diseases which involve apoptosis dysfunction, particularly in
cancer.
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